[HTML][HTML] Polypharmacy management in the older adults: a scoping review of available interventions

M Kurczewska-Michalak, P Lewek… - Frontiers in …, 2021 - frontiersin.org
Background: Polypharmacy paves the way for non-adherence, adverse drug reactions,
negative health outcomes, increased use of healthcare services and rising costs. Since it is …

Deprescribing in the older patient: a narrative review of challenges and solutions

H Wu, L Kouladjian O'Donnell, K Fujita… - … journal of general …, 2021 - Taylor & Francis
Polypharmacy is a major challenge in healthcare for older people, and is associated with
increased risks of adverse outcomes, such as delirium, falls, frailty, cognitive impairment and …

[HTML][HTML] A systematic review of potentially inappropriate medications use and related costs among the elderly

SK Malakouti, J Javan-Noughabi… - Value in health regional …, 2021 - Elsevier
Abstract Objective Potentially inappropriate medications (PIMs) use is a common
phenomenon among older adults. This paper aimed to perform a systematic literature review …

REview of potentially inappropriate MEDIcation pr [e] scribing in Seniors (REMEDI [e] S): French implicit and explicit criteria

B Roux, J Berthou-Contreras, JB Beuscart… - European Journal of …, 2021 - Springer
Purpose To establish a consensus on both explicit and implicit criteria in order to identify
potentially inappropriate prescribing (PIP) in French older people aged 75 years and over or …

Decision-support systems for managing polypharmacy in the elderly: A scoping review

A Mouazer, R Tsopra, K Sedki, C Letord… - Journal of Biomedical …, 2022 - Elsevier
Polypharmacy, the consuming of more than five drugs, is a public health problem. It can lead
to many interactions and adverse drug reactions and is very expensive. Therapeutic …

Implementation considerations of deprescribing interventions: a scoping review

J Wang, JY Shen, Y Conwell… - Journal of internal …, 2024 - Wiley Online Library
Over half of older adults experience polypharmacy, including medications that may be
inappropriate or unnecessary. Deprescribing, which is the process of discontinuing or …

[HTML][HTML] Polypharmacy in multiple sclerosis: current knowledge and future directions

J Thelen, V Zvonarev, S Lam, C Burkhardt… - Missouri …, 2021 - ncbi.nlm.nih.gov
Polypharmacy, or the daily use of five or more medications, is well documented in older
adults and linked to negative outcomes such as medication errors, adverse drug reactions …

Drug–drug interactions and prescription appropriateness in patients with COVID-19: a retrospective analysis from a reference hospital in Northern Italy

D Cattaneo, L Pasina, AP Maggioni, A Giacomelli… - Drugs & aging, 2020 - Springer
Background Patients hospitalised with severe acute respiratory syndrome coronavirus 2
[SARS-CoV-2; coronavirus 2019 disease (COVID-19)] infection are frequently older with co …

Multicomponent behavioral intervention to reduce exposure to anticholinergics in primary care older adults

NL Campbell, RJ Holden, Q Tang… - Journal of the …, 2021 - Wiley Online Library
Objective To test the impact of a multicomponent behavioral intervention to reduce the use of
high‐risk anticholinergic medications in primary care older adults. Design Cluster …

Frequency and acceptance of clinical decision support system-generated STOPP/START signals for hospitalised older patients with polypharmacy and multimorbidity

BTGM Sallevelt, CJA Huibers, JMJO Heij, TCG Egberts… - Drugs & aging, 2022 - Springer
Abstract Background The Screening Tool of Older Persons' Prescriptions
(STOPP)/Screening Tool to Alert to Right Treatment (START) instrument is used to evaluate …